Matches in Wikidata for { <http://www.wikidata.org/entity/Q63404883> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q63404883 description "clinical trial" @default.
- Q63404883 description "ensayu clínicu" @default.
- Q63404883 description "klinisch onderzoek" @default.
- Q63404883 description "клінічне випробування" @default.
- Q63404883 description "կլինիկական փորձարկում" @default.
- Q63404883 name "A Clinical Trial to Determine the Therapeutic Efficacy and Safety Between Cetuximab® (Produced by CinnaGen) and FOLFIRI Compared With Erbitux® (Cetuximab, Produced by Merck Company) and FOLFIRI for RAS Wild-type Metastatic Colorectal Cancer Pati" @default.
- Q63404883 type Item @default.
- Q63404883 label "A Clinical Trial to Determine the Therapeutic Efficacy and Safety Between Cetuximab® (Produced by CinnaGen) and FOLFIRI Compared With Erbitux® (Cetuximab, Produced by Merck Company) and FOLFIRI for RAS Wild-type Metastatic Colorectal Cancer Pati" @default.
- Q63404883 prefLabel "A Clinical Trial to Determine the Therapeutic Efficacy and Safety Between Cetuximab® (Produced by CinnaGen) and FOLFIRI Compared With Erbitux® (Cetuximab, Produced by Merck Company) and FOLFIRI for RAS Wild-type Metastatic Colorectal Cancer Pati" @default.
- Q63404883 P1132 Q63404883-21A24565-3E77-44E1-A881-4774D222F047 @default.
- Q63404883 P1476 Q63404883-6561710F-BA9A-4BA2-946C-F6707F64993A @default.
- Q63404883 P2899 Q63404883-0DCCE16A-35D4-4875-A350-E470751E357E @default.
- Q63404883 P3098 Q63404883-455DB6E8-EC3F-4C0C-96C6-ABEAC3D55FDC @default.
- Q63404883 P31 Q63404883-806EA981-5D9D-4509-9F96-BDB80DEAF3D5 @default.
- Q63404883 P4844 Q63404883-3C0555D8-12D3-4290-9DEE-741A49A2293C @default.
- Q63404883 P4844 Q63404883-5210BF08-3204-4697-A9F4-B95A1590E8DD @default.
- Q63404883 P4844 Q63404883-E8C0287F-6C57-421A-8C7F-D3283F80B8AC @default.
- Q63404883 P580 Q63404883-F7E9A05B-8739-4E7E-9814-46DFFEE081B8 @default.
- Q63404883 P582 Q63404883-65A051E3-A734-4F7F-8DC8-00C0E961CB3F @default.
- Q63404883 P6099 Q63404883-F365B214-E54F-41BC-BE8A-6390783970F8 @default.
- Q63404883 P8363 Q63404883-53C89CEE-214A-4946-A5BE-D37CBE9B9374 @default.
- Q63404883 P859 Q63404883-87C595B6-5E99-473C-8CF7-218A72166F30 @default.
- Q63404883 P1132 "+234" @default.
- Q63404883 P1476 "A Phase III, Randomized, Two Armed, Parallel, Double-blind, Active-controlled, Equivalency Clinical Trial to Determine the Therapeutic Efficacy and Safety Between Cetuximab® (Produced by CinnaGen) and FOLFIRI Compared With Erbitux® (Cetuximab, the Reference Drug, Produced by Merck Company) and FOLFIRI for RAS Wild-type Metastatic Colorectal Cancer Patients" @default.
- Q63404883 P2899 "+18" @default.
- Q63404883 P3098 "NCT03391934" @default.
- Q63404883 P31 Q30612 @default.
- Q63404883 P4844 Q238512 @default.
- Q63404883 P4844 Q412197 @default.
- Q63404883 P4844 Q420296 @default.
- Q63404883 P580 "2018-01-20T00:00:00Z" @default.
- Q63404883 P582 "2019-11-30T00:00:00Z" @default.
- Q63404883 P6099 Q42824827 @default.
- Q63404883 P8363 Q78089383 @default.
- Q63404883 P859 Q5121014 @default.